# Contact Script NAD — Editorial Inquiries on NAD+ Research

> Contact Script NAD with editorial questions or corrections about our NAD+ research summaries. We are an editorial publisher, not a clinic or vendor, and offer no medical advice.

Editorial questions, source suggestions, and corrections about our NAD+ summaries are welcome. Clinical questions are not something we can answer.

## What we can help with

Use the form to reach the Script NAD editorial desk about our NAD+ coverage. We welcome corrections, source suggestions, pointers to studies we should add, and questions about how we read a particular paper. If you think we have characterized a finding incorrectly — for instance, blurred the line between NAD+ and a precursor, or overstated a rodent result — tell us, and we will check it against the source.

## What we cannot help with

We cannot give medical advice, recommend doses, or tell you whether NAD+, NMN, NR, or any injection is appropriate for you. We are an editorial publisher, not a clinic, a pharmacy, or a vendor; we do not employ clinicians and we sell nothing. For any personal health decision, consult a qualified healthcare professional who can account for your individual circumstances.

## Editorial contact form

Send your name, an email address we can reply to, and your message. We read editorial correspondence about the NAD+ literature and respond to substantive questions and corrections as time allows. Please do not include personal health details — this is an editorial mailbox, not a clinical one.

---

One cold light on the NAD+ record — the coenzyme's age-related dimming and the NMN and NR precursor trials read scene by scene and cited to source, with no clinic behind the frame and nothing here prescribed, dispensed, or sold.